What type of study is this?

How treatment choices influence the onset and outcomes of uveitis ın juvenile idiopathic arthritis: a retrospective cohort study

View Full Paper

Ask AI

Bookmark

Higher frequency of new onset uveitis in JIA patients treated with biologics reflects important treatment considerations.
Among evaluated patients, 30 out of 365 on etanercept developed uveitis, compared to one on infliximab and none on adalimumab.
Retrospective cohort study analyzed 2,385 JIA patients, focusing particularly on biologics and methotrexate treatment outcomes.
Integration of uveitis risk assessment in JIA treatment strategies may help optimize patient care and outcomes.

No takes yet. Share an insight, caveat, or question.

Retrospective cohort analysis indicates higher uveitis occurrence in JIA patients on biologics, suggesting treatment adjustments may be needed.

Işık et al. (2025) studied this question.

View Full Paper

Ask AI

Bookmark

Retrospective cohort analysis indicates higher uveitis occurrence in JIA patients on biologics, suggesting treatment adjustments may be needed.